(Q43734715)

26 November 2017

title

Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study (English)

1 reference

26 November 2017

J Y Oh

1

1 reference

26 November 2017

E Barrett-Connor

series ordinal

2

1 reference

26 November 2017

Rancho Bernardo Study Group

series ordinal

3

1 reference

26 November 2017

publication date

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

60

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

132-137

1 reference

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Association of apolipoprotein (Apo)E genotype with plasma apo E levels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E Alleles and Risk of Coronary Disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Risk of diabetes in offspring of parents with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E polymorphism in health and disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Relationships between computed tomography tissue areas, thicknesses and total body composition

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: lessons learned from the Pima Indians

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.600207.X

7 January 2021

10.1034/J.1399-0004.2001.600207.X

Identifiers

DOI

1 reference

26 November 2017

1 reference